Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Joseph Jankovic, M.D. is Professor of Neurology, Distinguished Chair in Movement Disorders, and Founder and Director of the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC), Department of Neurology, Baylor College of Medicine, Houston, Texas. After completing his Neurology training at Columbia University, New York City, he joined the faculty of Baylor College of Medicine in 1977. Since that time he has led clinical and research team that focuses on etiology, pathophysiology, and experimental therapeutics of Parkinson’s disease and related neurodegenerative and movement disorders such as tremors, dystonia, Tourette syndrome, Huntington disease, restless legs syndrome, tardive dyskinesia, and paroxysmal dyskinesias. Under the direction of Dr.
Yawning-related tremor in patients with Parkinson's disease.
The "Hallett Sign" of Functional Jerky Movement Disorder.
Genome-Wide Association Analysis of Tic Disorders Reveals 6 Independent Risk Loci and Highlights Tic-Associated Cell Types and Brain Circuitry
Skin Phosphorylated Alpha-Synuclein in Patients With Essential Tremor
Definition and Classification of Dystonia
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges
Tardive dyskinesia versus tardive syndrome. What is in a name?
Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders.
Response to the letter "Reassessing the hypothesis of essential tremor as a prodromal feature of Parkinson's disease".
Corticobasal Syndrome: Are There Central or Peripheral Triggers?
Rare but Relevant: Assessing Variants in Dystonia-linked Genes in Parkinson’s Disease
Extrapyramidal System/Symptoms/Signs Should Be Retired.
Essential tremor as a prodromal feature of Parkinson's disease.
Leg stereotypy syndrome: phenomenological and quantitative analysis.
Isolated Cervical Dystonia: Diagnosis and Classification
Linking the cerebellum to Parkinson disease: an update.
Isolated Cervical Dystonia: Diagnosis and Classification.
Embracing Monogenic Parkinson's Disease: The <scp>MJFF</scp> Global Genetic <scp>PD</scp> Cohort
COVID19-associated new-onset movement disorders: a follow-up study
Peripherally-induced Movement Disorders: An Update.
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson's disease?
The Clinical Characterization of Blocking Tics in Patients With Tourette Syndrome.
Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease
The Conundrum of Dystonia in Essential Tremor Patients: How does One Classify these Cases?
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson's disease.
Botulinum Toxin in Movement Disorders: An Update